- Impact of GGCX polymorphisms on warfarin doserequirements in atrial fibrillation patients
Nian-Xin JIANG et al, 2017, TURKISH JOURNAL OF MEDICAL SCIENCES CrossRef - Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population
Letícia C. Tavares et al, 2018, European Journal of Clinical Pharmacology CrossRef - Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients
Suli Zhang et al, 2024, Pharmacogenetics and Genomics CrossRef - Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials
Ting Yang et al, 2019, Journal of Clinical Pharmacy and Therapeutics CrossRef - Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the Warfarin Maintenance Dose in Brazilian Patients
Emílio Itamar de Freitas Campos et al, 2023, Pharmacogenomics CrossRef - Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation
Ye Zhu et al, 2023, European Journal of Clinical Pharmacology CrossRef - Warfarin Pharmacogenomics in Diverse Populations
Justin B. Kaye et al, 2017, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy CrossRef - Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
Cristina Lucía Dávila-Fajardo et al, 2019, Genes CrossRef - GENETIC POLYMORPHISMS OF CYTOCHROME P450 2C9, VITAMIN K EPOXIDE-REDUCTASE SUBUNIT 1 AND WARFARIN DOSING IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION
A O Rubanenko et al, 2016, Science and Innovations in Medicine CrossRef - Genotype-Guided Warfarin Therapy: Current Status
Letícia C Tavares et al, 2018, Pharmacogenomics CrossRef - Ethnic Diversity and Warfarin Pharmacogenomics
Innocent G. Asiimwe et al, 2022, Frontiers in Pharmacology CrossRef